Health technology assessments and hospital access for health technology​

Rely on DRA’s experts to help you with the hospital access and hospital tenders for your medical devices in the Finnish market. Did you know that a Health Technology Assessment (HTA) is needed before your device can be reimbursed or used in hospitals? DRA can give you guidance on the EU regulations, including explanations of the requirements and the benefits, and we can also perform HTAs for you.

Our health technology assessment and hospital access services include:

  • Health technology assessments (HTA) ​
  • Localising clinical and health economic assessments
  • Budget Impact models (BIM) ​
  • Treatment pathway evaluations ​
  • Landscape analysis​
  • Full support with hospital access and hospital tenders
  • Guidance in FinCCHTArequirements​ and in the Fimea COHERE procedure ​
  • Interviewing healthcare professionals​ and communication with authorities

At DRA, we know the Finnish medical system and the EU regulations inside out. We will perform Health Technology Assessments for you and take all relevant factors into account. This will result in an accurate picture of the overall costs, benefits and competitiveness of your medical device (MD) and in vitro diagnostic (IVD) medical device.​

As part of our services for hospital-only medical devices, DRA will monitor the hospital tenders published in Finland to identify new opportunities for your business. With this maintenance phase service, we will notify your company when relevant tenders are published in the HILMA system and we can also translate the hospital requirements for you – hospital pharmacies usually publish these only in the Finnish language.

In the medical device market it can be difficult to set a competitive but also profitable price for a device. At DRA, we can gather and review market and competitor information, which you can then use to successfully place your open care or hospital-only device on the market.​